Providence Therapeutics

About:

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

Website: https://www.providencetherapeutics.com

Top Investors: Bill & Melinda Gates Foundation

Description:

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat advanced ovarian cancer. The company's vaccine identifies tumor mutations and elicits an immune response against the tumor cells, enabling users to treat themselves and live life to the fullest. It aims to provide safe and effective medicines for people suffering from diseases with unmet medical needs. Scott Leary, Eric Marcusson, and Bradley Sorenson established the company in Toronto, Ontario in 2015.

Total Funding Amount:

$5.59M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2015-01-01

Contact Email:

info(AT)providencetherapeutics.com

Founders:

Brad Sorenson, Eric Marcusson, Scott Leary

Number of Employees:

11-50

Last Funding Date:

2021-12-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai